||Optional Breakfast Sessions - Choose from 8
(You must register and pay separately for breakfast sessions during the registration process.)
Breakfast E: Quality and Technique in Colonoscopy: Doing It Better
Moderator: Jason B. Samarasena, MD, FACG
- Pre-Procedural Quality: Getting Them In and Getting Them Clean
Jason B. Samarasena, MD, FACG
Discuss interventions to improve colonoscopy preparation quality and patient tolerance, and ways to reduce procedure cancellation through use of navigators, apps, and improved dietary restrictions.
- Intra-Procedural Quality: Technology, Techniques, and Tips to Improve Effectiveness
Seth A. Gross, MD, FACG
Describe the current tools and techniques used to improve quality during a colonoscopy, including assistive devices, water techniques, and computer analysis.
- Post-Procedural Quality: How Did We Do and Can We Do Better?
Irving M. Pike, MD, FACG
Summarize quality metrics such as ADR, withdrawal, surveillance intervals, adverse event tracking, and other possible interventions to increase quality.
Breakfast F: Hot Topics in Liver Disease
Moderator: Renuka Umashanker, MD, FACG
- Approach to the Patient With Solid and Cystic Liver Lesions
Renuka Umashanker, MD, FACG
Outline current guideline recommendations in the evaluation, diagnosis, and management of patients with new liver lesions.
- Autoimmune Liver Disorders: PBC, PSC, Autoimmune Hepatitis
David E. Bernstein, MD, FACG
Discuss current and evolving diagnostic and treatment strategies in the management of autoimmune liver disorders, and the application of new therapeutic modalities in clinical practice.
- Evaluation of a Patient With Alcoholic Liver Disease
Vijay H. Shah, MD, FACG
Summarize current guidelines in the management of patients with alcoholic liver disease, and discuss evidence-based strategies for implementation in clinical practice.
Breakfast G: GERD – Weighing the Risks and Benefits
Moderator: Philip O. Katz, MD, MACG
- GERD Diagnostics – Complementary Not Competitive
C. Prakash Gyawali, MD, FACG
Summarize the available techniques and develop a management algorithm for the diagnosis of GERD.
- Personalized GERD Management
Rena H. Yadlapati, MD
Describe the role of medical, endoscopic, or surgical management based on GERD phenotypes.
- Proton Pump Inhibitors: How to Help Get Your Patients Off of Them
Philip O. Katz, MD, MACG
Identify possible strategies to help your patients discontinue the use of PPIs.
Breakfast H: Optimizing IBD Management
Moderator: Laura E. Raffals, MD, MS, FACG
- Treating to Target – What Exactly Should Our Target Be Now?
Kara M. De Felice, MD
Define the concept of treat-to-target for patients with IBD.
- Looking Into the IBD Crystal Ball – Predicting the Course of Disease
Laura E. Raffals, MD, MS, FACG
Evaluate available tools for predicting disease course in patients with IBD.
- Choosing the Right Therapy For Your Newly Diagnosed IBD Patient
Adam S. Cheifetz, MD, FACG
Identify how to select the best initial therapy for your patient with IBD.
Breakfast I: Endoscopic Management of Perforations and Fistulae
(This session will begin with two didactic lectures followed by a hands-on demonstration in the Hands-On Endoscopy Workshop Center in the Exhibit Hall. The hands-on workshop portion of the session does not offer CME.)
Moderator: Laith H. Jamil, MD, FACG
- Strategies for Chronic Fistulae
Christopher C. Thompson, MD, MSc, FACG
Describe endoscopic techniques available for managing chronic fistulae.
- Medical and Endoscopic Management of Luminal Perforations
Laith H. Jamil, MD, FACG
Discuss both medical and endoscopic tools and techniques available for managing luminal perforations.
- Hands-On Demonstration in the Exhibit Hall
Laith H. Jamil, MD, FACG, Shivangi T. Kothari, MD, FACG, and Christopher C. Thompson, MD, MSc, FACG
Breakfast J: Esophageal Endotherapy
Moderator: Gary W. Falk, MD, MS, FACG
- Barrett’s Esophagus: Burn, Freeze, or Cut?
Gary W. Falk, MD, MS, FACG
Describe techniques of RFA, cryoablation, and EMR/ESD, as well as pros and cons, indications, and outcomes of each technique for treating Barrett’s esophagus.
- Achalasia: Inject, Dilate, or Cut?
Walter W. Chan, MD
Evaluate techniques of botox injection, pneumatic dilation, and POEM, as well as pros and cons, indications, and outcomes of each technique in treating achalasia.
- Strictures: Dilate, Cut, or Stent?
Mihir S. Wagh, MD, FACG
Compare techniques of dilation, endoscopic incisional therapy, and stenting for benign and malignant esophageal strictures, as well as pros and cons, indications, and outcomes of each technique.
Breakfast K: Pancreaticobiliary
Moderator: Vivek Kaul, MD, FACG
- Management of Acute Pancreatitis: The First 48 Hours
Vikesh K. Singh, MD
Identify the guidelines and evidence-based early management of patients with acute pancreatitis and how it impacts outcome.
- ERCP Complications: Prediction, Prevention, and Management
Vivek Kaul, MD, FACG
Describe how to best predict, prevent, and manage ERCP complications based on current scientific evidence and guidelines.
- Management of Complex Common Bile Duct Stones
Mansour A. Parsi, MD
Discuss the state-of-the-art approach to management of large and difficult to remove common bile duct stones.
Breakfast L: What Is New in Enteropathy?
Moderator: William D. Chey, MD, FACG
- Diagnosis and Management of Celiac Disease
Joseph A. Murray, MD, FACG
Discuss the diagnosis and management of celiac disease and its mimics.
- Non-Celiac Gluten Sensitivity
William D. Chey, MD, FACG
Describe the diagnosis and management of patients with non-celiac gluten sensitivity.
- What Is New in Leaky Gut?
Julia J. Liu, MD, FACG
Outline laboratory and endoscopic findings of leaky gut, and recognize the role of leaky gut in the pathogenesis of chronic intestinal disease.
||Simultaneous Symposia Session 3 - Choose from 2
Symposium 3A: Current Challenges and Controversies in the Management of Viral Hepatitis
Moderator: Sonali Paul, MD
- How to Use Non-Invasive Liver Fibrosis Tests in Clinical Practice
Sonali Paul, MD
Identify the appropriate use of non-invasive liver fibrosis tests, such as serum fibrosis assays and imaging-based elastography, in clinical practice for patients with viral hepatitis and other chronic liver disorders.
- Challenges in Hepatitis C Management: DAA Failures, Special Populations, and Controversies
Mitchell L. Shiffman, MD, FACG
Describe the evidence addressing current challenges and controversies in HCV therapy, including treatment of DAA failures and special populations, and the association between DAAs and both HCC and HBV reactivation.
- Challenges in Hepatitis B Management: HBV Reactivation
James S. Park, MD, FACG
Discuss evidence-based approaches to challenging issues in hepatitis B management, including the care of chronic HBV in pregnancy, and the evaluation, prevention, and management of HBV reactivation in patients undergoing immunosuppressive drug therapy.
Symposium 3B: Battling Physician Burnout: It Will Take a Village
Moderator: Carol A. Burke, MD, FACG
- Recognizing Burnout
Christina M. Surawicz, MD, MACG
Recognize and identify burnout predictors.
- What Can Your Institution or Practice Do?
Joseph C. Anderson, MD, MHCDS, FACG
Describe what your institution or practice can do to mitigate burnout.
- The Pathway to Physician Wellness
Carol A. Burke, MD, FACG
Identify ways to have work-life balance.
||Simultaneous Symposia Session 4 - Choose from 3
Symposium 4A: Interdisciplinary Management of Variceal Bleeding
Moderator: Guadalupe Garcia-Tsao, MD, FACG
- Medical Management of Portal Hypertensive Bleeding
Guadalupe Garcia-Tsao, MD, FACG
Describe medical management of variceal bleeding as well as its appropriate surveillance.
- Comprehensive Endoscopic Management of Esophageal and Gastric Varices
Uzma D. Siddiqui, MD
Assess standard as well as state-of-the-art endoscopic and EUS-guided techniques for managing esophageal and gastric variceal bleeding.
- The Role of Interventional Radiology in the Management of Variceal Bleeding
Michael C. Soulen, MD
Interpret radiology techniques as well as appropriate indications to manage esophageal and gastric variceal bleeding.
Symposium 4B: The Colonic Microbiome: C. difficile and Beyond
Moderator: Lawrence J. Brandt, MD, MACG
- The Colonic Microbiome: What Do We Know in 2018?
Lawrence J. Brandt, MD, MACG
Elaborate on the current state of knowledge about the human microbiome; can we test, can we manipulate?
- Fecal Microbiota Transplant (FMT) in C. difficile infection
Colleen R. Kelly, MD, FACG
Explain the biology, technique, and outcomes of FMT in patients with C. difficile infection.
- Fecal Microbiota Transplant (FMT) for Other Emerging Indications: Potential and Promise
Paul Moayyedi, MD, MB ChB, PhD, MPH, FACG
Discuss the emerging data on the efficacy of FMT for other indications beyond C. difficile, including IBD, IBS, obesity, and hepatic encephalopathy.
Symposium 4C: Burning Issues in Barrett’s Esophagus
Moderator: Prasad G. Iyer, MD, FACG
- Screening and Surveillance – Why and How?
Prasad G. Iyer, MD, FACG
Recognize indications for screening and list surveillance recommendations for BE.
- Predicting Progression to Cancer – The Holy Grail
Nicholas J. Shaheen, MD, MPH, FACG
Describe clinical features and biomarkers associated with progression to high grade dysplasia / cancer in Barrett’s esophagus.
- Tackling Issues in Endoscopic Therapy
Vani J.A. Konda, MD
Discuss issues relevant to the management of BE patients without dysplasia, with low grade dysplasia, and after successful ablation.